Alterations of cardiac sympathetic neurotransmitter activity in congestive heart failure.
D000818:Animals; D001665:Binding Sites; D006332:Cardiomegaly / Q000503:physiopathology; D002415:Cats; D004285:Dogs; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects / Q000294:innervation*; D006333:Heart Failure / Q000503:physiopathology*; D006352:Heart Ventricles / Q000503:physiopathology; D006801:Humans; D007668:Kidney / Q000032:analysis; D009206:Myocardium / Q000032:analysis; D009638:Norepinephrine / Q000032:analysis / Q000096:biosynthesis / Q000097:blood / Q000494:pharmacology / Q000502:physiology / Q000652:urine; D010275:Parasympathetic Nervous System / Q000503:physiopathology; D005082:Physical Exertion; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D013564:Sympathetic Nervous System / Q000503:physiopathology*; D009435:Synaptic Transmission; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D014446:Tyrosine 3-Monooxygenase; D009638:Norepinephrine